Literature DB >> 15814573

Possible involvement of CPI-17 in augmented bronchial smooth muscle contraction in antigen-induced airway hyper-responsive rats.

Hiroyasu Sakai1, Yoshihiko Chiba, Tomona Hirano, Miwa Misawa.   

Abstract

Airway hyper-responsiveness (AHR) associated with heightened airway resistance and inflammation is a characteristic feature of asthma. It has been demonstrated that contractile responsiveness and Ca(2+) sensitization to acetylcholine (ACh) in repeated antigen challenge-induced airway hyper-responsive bronchial preparation were significantly increased. The CPI-17 (PKC-potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kDa) is activated by protein kinase C and acts on a myosin light-chain phosphatase-specific target. The aim of the present study was to explore the role of CPI-17 in hyper-responsiveness of bronchial smooth muscle in antigen-induced AHR rats. In immunoblotting, the levels of expression of CPI-17 mRNA and protein were significantly increased in bronchus from rats that were repeatedly challenged with antigen. ACh-induced CPI-17 phosphorylation and translocation to membrane fraction were also significantly increased in bronchus from antigen-challenged rats. In conclusion, we suggest that augmented expression and activation of CPI-17 observed in the hyper-responsive bronchial smooth muscle might be responsible for the enhanced ACh-induced Ca(2+) sensitization of bronchial smooth muscle contraction associated with AHR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814573     DOI: 10.1124/mol.104.004325

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  20 in total

1.  Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells.

Authors:  Jee In Kim; Mark Urban; Garbo D Young; Masumi Eto
Journal:  Am J Physiol Cell Physiol       Date:  2012-04-25       Impact factor: 4.249

2.  A functional interaction between CPI-17 and RACK1 proteins in bronchial smooth muscle cells.

Authors:  Yoshihiko Chiba; Miki Tanabe; Hiroyasu Sakai; Shioko Kimura; Miwa Misawa
Journal:  Biochem Biophys Res Commun       Date:  2010-09-25       Impact factor: 3.575

3.  Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor.

Authors:  Masumi Eto; Toshio Kitazawa; Fumiko Matsuzawa; Sei-Ichi Aikawa; Jason A Kirkbride; Noriyoshi Isozumi; Yumi Nishimura; David L Brautigan; Shin-Ya Ohki
Journal:  Structure       Date:  2007-12       Impact factor: 5.006

Review 4.  Endogenous inhibitor proteins that connect Ser/Thr kinases and phosphatases in cell signaling.

Authors:  Masumi Eto; David L Brautigan
Journal:  IUBMB Life       Date:  2012-07-20       Impact factor: 3.885

5.  MAG-EPA and 17,18-EpETE target cytoplasmic signalling pathways to reduce short-term airway hyperresponsiveness.

Authors:  Rayan Khaddaj-Mallat; Éric Rousseau
Journal:  Pflugers Arch       Date:  2014-08-13       Impact factor: 3.657

6.  GATA-6 and NF-κB activate CPI-17 gene transcription and regulate Ca2+ sensitization of smooth muscle contraction.

Authors:  Ettickan Boopathi; Joseph A Hypolite; Stephen A Zderic; Cristiano Mendes Gomes; Bruce Malkowicz; Hsiou-Chi Liou; Alan J Wein; Samuel Chacko
Journal:  Mol Cell Biol       Date:  2012-12-28       Impact factor: 4.272

7.  Physiological vs. pharmacological signalling to myosin phosphorylation in airway smooth muscle.

Authors:  Ning Gao; Ming-Ho Tsai; Audrey N Chang; Weiqi He; Cai-Ping Chen; Minsheng Zhu; Kristine E Kamm; James T Stull
Journal:  J Physiol       Date:  2017-08-24       Impact factor: 5.182

Review 8.  Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors.

Authors:  Masumi Eto
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

9.  Expression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation.

Authors:  Jee In Kim; Garbo D Young; Li Jin; Avril V Somlyo; Masumi Eto
Journal:  Histochem Cell Biol       Date:  2009-05-13       Impact factor: 4.304

10.  Downregulation of CPI-17 contributes to dysfunctional motility in chronic intestinal inflammation model mice and ulcerative colitis patients.

Authors:  Takashi Ohama; Masatoshi Hori; Masahiko Fujisawa; Masaharu Kiyosue; Masaki Hashimoto; Yuka Ikenoue; Yoshio Jinno; Hiroto Miwa; Takayuki Matsumoto; Takahisa Murata; Hiroshi Ozaki
Journal:  J Gastroenterol       Date:  2008-11-18       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.